Predictors of Postpartum Persisting Hypertension Among Women with Preeclampsia Admitted at Carlos Manuel de Cèspedes Teaching Hospital, Cuba

• Published in: International journal of women's health 2020-01, Vol.12, p.765-771
• Main Authors: Fajardo Tornes, Yarine, Nápoles Mèndez, Danilo, Alvarez Aliaga, Alexis, Santson Ayebare, David, Ssebuufu, Robinson, Byonanuwe, Simon
• Format: Article
• Language: English
• Subjects: Blood pressure; Creatinine; Flow velocity; Health care industry; Hypertension; Information management; International economic relations; Kidney diseases; Laboratories; Medical research; Morbidity; Mortality; Original Research; Patients; persisting hypertension; postpartum hypertension; Postpartum period; Preeclampsia; pyruvate glutamic transaminase; serum creatinine; Teaching hospitals; Ultrasonic imaging; Womens health
• ISSN: 1179-1411; 1179-1411
• DOI: 10.2147/IJWH.S263718

We established the prevalence and predictors of persisting hypertension in women with preeclampsia admitted at the Carlos Manuel de Cèspedes Teaching Hospital in Cuba so as to guide the health-care providers in early identification of the patients at risk for timely intervention. A three-year prospective cohort study was conducted between March 2017 and March 2020. A cohort of 178 women diagnosed with preeclampsia at the hypertension unit of Carlos Manuel de Cèspedes Teaching Hospital were recruited. Interviewer administered questionnaires and laboratory and ultrasound scan result forms were used to collect the data. Binary logistic regression was conducted to determine the predictors. All data analyses were conducted using STATA version 14.2. Forty-five (27.8%) of the studied 162 patients were still hypertensive at 12 weeks postpartum. Maternal age of 35 years or more (aRR=1.14,95% CI:1.131-4.847, =0.022), early onset preeclampsia (before 34 weeks of gestation) (aRR=7.93, 95% CI:1.812-34.684, =0.006), and elevated serum creatinine levels of more than 0.8mg/dl (aRR=1.35, 95% CI:1.241-3.606, =0.032) were the independent predictors of persisting hypertension at 12 weeks postpartum. Recognition of these predictors and close follow-up of patients with preeclampsia will improve the ability to diagnose and monitor women likely to develop persisting hypertension before its onset for timely interventions.